Statistics

Total Visits

Views
The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trial 48

Total Visits per Month

July 2019 August 2019 September 2019 October 2019 November 2019 December 2019 January 2020
The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trial 0 0 0 3 5 4 1

File Downloads

Views

Top Country Views

Views
France 14
United States 13
Australia 7
China 3
Germany 1
Russia 1

Top City Views

Views
Kaleen 7
Fairfield 4
Dearborn 3
Beijing 2
Buffalo 2
Cambridge 2
Ashburn 1
Saint Petersburg 1